Calyxt, Inc. is a plant-based biotechnology platform company. The Company is focused on research and development, including gene editing, plant breeding, and trait development. It specializes in engineering plant metabolisms. The Company operates through the development and commercialization of products derived from plant cells. Its platform provides plant-based synthetic biology solutions to customers across multiple industries. The Company has engineered plant metabolism into products including soybeans with improved fatty-acid profiles and alfalfa able to be better digested by livestock. Its product pipeline includes hemp, winter oats, and high saturated fat soybeans. Hemp serves a range of varieties of materials science needs, including strengthening plastics and reducing petroleum-based content. The Company’s customers include seed companies, biotechnology companies, germplasm providers, agricultural processors, and others in the crop’s supply chain and growers.